Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Rheumatology
Volume 2014, Article ID 949317, 3 pages
http://dx.doi.org/10.1155/2014/949317
Case Report

Occurrence of Psoriatic Arthritis during Interferon Beta 1a Treatment for Multiple Sclerosis

1Clinical Investigation Center Biotherapy INSERM CIC-1431, FHU INCREASE, University Hospital Besançon, Place Saint Jacques, 25000 Besançon, France
2Department of Rheumatology, University Hospital Besançon, 25000 Besançon, France
3Department of Therapeutics, University of Franche-Comté, 25000 Besançon, France
4Pathogens and Inflammation Laboratory, University of Franche-Comté, UPRES EA 4266, SFR FED 4234, 25000 Besançon, France
5Department of Neurology, University Hospital Besançon, 25000 Besançon, France
6Department of Rheumatology, Belfort-Montbéliard Hospital, 90000 Belfort, France
7Department of Neurology, Belfort-Montbéliard Hospital, 90000 Belfort, France

Received 16 February 2014; Accepted 31 March 2014; Published 15 April 2014

Academic Editor: Masataka Kuwana

Copyright © 2014 Éric Toussirot et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. E. Munschauer III and R. P. Kinkel, “Managing side effects of interferon-beta in patients with relapsing- remitting multiple sclerosis,” Clinical Therapeutics, vol. 19, no. 5, pp. 883–893, 1997. View at Publisher · View at Google Scholar · View at Scopus
  2. W. Taylor, D. Gladman, P. Helliwell, A. Marchesoni, P. Mease, and H. Mielants, “Classification criteria for psoriatic arthritis: development of new criteria from a large international study,” Arthritis and Rheumatism, vol. 54, no. 8, pp. 2665–2673, 2006. View at Publisher · View at Google Scholar · View at Scopus
  3. G. F. Webster, R. L. Knobler, F. D. Lublin, E. M. Kramer, and L. R. Hochman, “Cutaneous ulcerations and pustular psoriasis flare caused by recombinant interferon beta injections in patients with multiple sclerosis,” Journal of the American Academy of Dermatology, vol. 34, no. 2, pp. 365–367, 1996. View at Google Scholar · View at Scopus
  4. L. Kowalzick and G. Webster, “Psoriasis flare caused by recombinant interferon beta injections,” Journal of the American Academy of Dermatology, vol. 36, no. 3, p. 501, 1997. View at Google Scholar · View at Scopus
  5. I. López-Lerma, P. Iranzo, and C. Herrero, “New-onset psoriasis in a patient treated with interferon beta-1a,” British Journal of Dermatology, vol. 160, no. 3, pp. 716–717, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. L. La Mantia and F. Capsoni, “Psoriasis during interferon beta treatment for multiple sclerosis,” Neurological Sciences, vol. 31, no. 3, pp. 337–339, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. S. Alsalameh, B. Manger, P. Kern, and J. Kalden, “New onset of rheumatoid arthritis during interferon β-1b treatment in a patient with multiple sclerosis: comment on the case report by jabaily and thompson,” Arthritis and Rheumatism, vol. 41, no. 4, p. 754, 1998. View at Google Scholar · View at Scopus
  8. M. Buttmann, M. Goebeler, A. Toksoy et al., “Subcutaneous Interferon-β injections in patients with multiple sclerosis initiate inflammatory skin reactions by local chemokine induction,” Journal of Neuroimmunology, vol. 168, no. 1-2, pp. 175–182, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. R. C. Axtell, C. Raman, and L. Steinman, “Interferon-β exacerbates Th17-mediated inflammatory disease,” Trends in Immunology, vol. 32, no. 6, pp. 272–277, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. V. S. Ramgolam, Y. Sha, J. Jin, X. Zhang, and S. Markovic-Plese, “IFN-β inhibits human Th17 cell differentiation,” Journal of Immunology, vol. 183, no. 8, pp. 5418–5427, 2009. View at Publisher · View at Google Scholar · View at Scopus